217 related articles for article (PubMed ID: 17361036)
1. Possible compensatory events in adult Down syndrome brain prior to the development of Alzheimer disease neuropathology: targets for nonpharmacological intervention.
Head E; Lott IT; Patterson D; Doran E; Haier RJ
J Alzheimers Dis; 2007 Mar; 11(1):61-76. PubMed ID: 17361036
[TBL] [Abstract][Full Text] [Related]
2. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
[TBL] [Abstract][Full Text] [Related]
3. [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
Asai M; Kawakubo T; Mori R; Iwata N
Yakugaku Zasshi; 2017; 137(7):801-805. PubMed ID: 28674290
[TBL] [Abstract][Full Text] [Related]
4. Neuronal overexpression of Alzheimer's disease and Down's syndrome associated DYRK1A/minibrain gene alters motor decline, neurodegeneration and synaptic plasticity in Drosophila.
Lowe SA; Usowicz MM; Hodge JJL
Neurobiol Dis; 2019 May; 125():107-114. PubMed ID: 30703437
[TBL] [Abstract][Full Text] [Related]
5. Regulator of calcineurin 1 (RCAN1) facilitates neuronal apoptosis through caspase-3 activation.
Sun X; Wu Y; Chen B; Zhang Z; Zhou W; Tong Y; Yuan J; Xia K; Gronemeyer H; Flavell RA; Song W
J Biol Chem; 2011 Mar; 286(11):9049-62. PubMed ID: 21216952
[TBL] [Abstract][Full Text] [Related]
6. Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology.
Head E; Lott IT; Wilcock DM; Lemere CA
Curr Alzheimer Res; 2016; 13(1):18-29. PubMed ID: 26651341
[TBL] [Abstract][Full Text] [Related]
7. [Molecular Mechanism Underlying Abnormal Differentiation of Neural Progenitor Cells in the Developing Down Syndrome Brain].
Kurabayashi N; Sanada K
Yakugaku Zasshi; 2017; 137(7):795-800. PubMed ID: 28674289
[TBL] [Abstract][Full Text] [Related]
8. Two key genes closely implicated with the neuropathological characteristics in Down syndrome: DYRK1A and RCAN1.
Park J; Oh Y; Chung KC
BMB Rep; 2009 Jan; 42(1):6-15. PubMed ID: 19192387
[TBL] [Abstract][Full Text] [Related]
9. Developmental deficits and staging of dynamics of age associated Alzheimer's disease neurodegeneration and neuronal loss in subjects with Down syndrome.
Wegiel J; Flory M; Kuchna I; Nowicki K; Wegiel J; Ma SY; Zhong N; Bobrowicz TW; de Leon M; Lai F; Silverman WP; Wisniewski T
Acta Neuropathol Commun; 2022 Jan; 10(1):2. PubMed ID: 34983655
[TBL] [Abstract][Full Text] [Related]
10. Beta-amyloid controls altered Reelin expression and processing in Alzheimer's disease.
Botella-López A; Cuchillo-Ibáñez I; Cotrufo T; Mok SS; Li QX; Barquero MS; Dierssen M; Soriano E; Sáez-Valero J
Neurobiol Dis; 2010 Mar; 37(3):682-91. PubMed ID: 20025970
[TBL] [Abstract][Full Text] [Related]
11. Role of tau protein in neuronal damage in Alzheimer's disease and Down syndrome.
Cárdenas AM; Ardiles AO; Barraza N; Baéz-Matus X; Caviedes P
Arch Med Res; 2012 Nov; 43(8):645-54. PubMed ID: 23142525
[TBL] [Abstract][Full Text] [Related]
12. Aberrant protein expression of transcription factors BACH1 and ERG, both encoded on chromosome 21, in brains of patients with Down syndrome and Alzheimer's disease.
Shim KS; Ferrando-Miguel R; Lubec G
J Neural Transm Suppl; 2003; (67):39-49. PubMed ID: 15068237
[TBL] [Abstract][Full Text] [Related]
13. Neprilysin Is Suppressed by Dual-Specificity Tyrosine-Phosphorylation Regulated Kinase 1A (DYRK1A) in Down-Syndrome-Derived Fibroblasts.
Kawakubo T; Mori R; Shirotani K; Iwata N; Asai M
Biol Pharm Bull; 2017; 40(3):327-333. PubMed ID: 28250274
[TBL] [Abstract][Full Text] [Related]
14. Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease.
Ryoo SR; Cho HJ; Lee HW; Jeong HK; Radnaabazar C; Kim YS; Kim MJ; Son MY; Seo H; Chung SH; Song WJ
J Neurochem; 2008 Mar; 104(5):1333-44. PubMed ID: 18005339
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling in the adult Down syndrome brain.
Lockstone HE; Harris LW; Swatton JE; Wayland MT; Holland AJ; Bahn S
Genomics; 2007 Dec; 90(6):647-60. PubMed ID: 17950572
[TBL] [Abstract][Full Text] [Related]
16. Amyloid-β precursor protein facilitates the regulator of calcineurin 1-mediated apoptosis by downregulating proteasome subunit α type-5 and proteasome subunit β type-7.
Wu Y; Deng Y; Zhang S; Luo Y; Cai F; Zhang Z; Zhou W; Li T; Song W
Neurobiol Aging; 2015 Jan; 36(1):169-77. PubMed ID: 25194880
[TBL] [Abstract][Full Text] [Related]
17. The spatio-temporal and subcellular expression of the candidate Down syndrome gene Mnb/Dyrk1A in the developing mouse brain suggests distinct sequential roles in neuronal development.
Hämmerle B; Elizalde C; Tejedor FJ
Eur J Neurosci; 2008 Mar; 27(5):1061-74. PubMed ID: 18364031
[TBL] [Abstract][Full Text] [Related]
18. The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease.
Kimura R; Kamino K; Yamamoto M; Nuripa A; Kida T; Kazui H; Hashimoto R; Tanaka T; Kudo T; Yamagata H; Tabara Y; Miki T; Akatsu H; Kosaka K; Funakoshi E; Nishitomi K; Sakaguchi G; Kato A; Hattori H; Uema T; Takeda M
Hum Mol Genet; 2007 Jan; 16(1):15-23. PubMed ID: 17135279
[TBL] [Abstract][Full Text] [Related]
19. Reduction of chromatin assembly factor 1 p60 and C21orf2 protein, encoded on chromosome 21, in Down syndrome brain.
Shim KS; Bergelson JM; Furuse M; Ovod V; Krude T; Lubec G
J Neural Transm Suppl; 2003; (67):117-28. PubMed ID: 15068244
[TBL] [Abstract][Full Text] [Related]
20. Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome.
Dowjat WK; Adayev T; Kuchna I; Nowicki K; Palminiello S; Hwang YW; Wegiel J
Neurosci Lett; 2007 Feb; 413(1):77-81. PubMed ID: 17145134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]